Background:Abnormalities in computed tomography myocardial perfusion has been associated with coronary artery disease and major adverse cardiovascular events (MACE). We sought to investigate if subendocardial attenuation using coronary computed tomography angiography predicts MACE 30 days postelective noncardiac surgery.Methods:
Using a 17-segment model, coronary computed tomography angiography images were analyzed for subendocardial and transmural attenuation and the corresponding blood pool. The segment with the lowest subendocardial attenuation and transmural attenuation were normalized to the segment with the highest subendocardial and transmural attenuation, respectively (SUB
normalized
, and TRANS
normalized
, respectively). We evaluated the independent and incremental value of myocardial attenuation to predict the composite of cardiovascular death or nonfatal myocardial infarction.
Results:
Of a total of 995 coronary CTA VISION (Coronary Computed Tomographic Angiography and Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study) patients, 735 had available images and complete data for these analyses. Among these patients, 60 had MACE. Based on Revised Cardiovascular Risk Index, 257, 302, 138, and 38 patients had scores of 0, 1, 2, and ≥3, respectively. On coronary computed tomography angiography, 75 patients had normal coronary arteries, 297 patients had nonobstructive coronary artery disease, 264 patients had obstructive disease, and 99 patients had extensive obstructive coronary artery disease. SUB
normalized
was an independent and incremental predictor of events in the model that included Revised Cardiovascular Risk Index and coronary artery disease severity. Compared with patients in the highest tertile of SUB
normalized
, patients in the second and first tertiles had an increased hazards ratio for events (2.23 [95% CI, 1.091–4.551] and 2.36 [95% CI, 1.16–4.81], respectively). TRANS
normalized
, as a continuous variable, was also found to be a predictor of MACE (
P
=0.027).
Conclusions:
Our study demonstrates that SUB
normalized
and TRANS
normalized
are independent and incremental predictors of MACE 30 days after elective noncardiac surgery.
Registration:
URL:
https://www.clinicaltrials.gov
; Unique identifier: NCT01635309.
